Imiglucerase, also known as Cerezyme, is suitable for adult patients and children with type 1 Gaucher disease aged 2 years and above, and it is an important drug for the treatment of type 1 Gaucher disease. Imiglucerase has been marketed in China but has not yet been included in China's medical insurance. Patients can purchase Imiglucerase through various channels such as hospitals and pharmacies in China.

What are the purchasing channels for Imiglucerase?

The purchasing channels for Imiglucerase are relatively specific and standardized. Patients and their families should pay attention to the following formal channels when seeking to purchase:

Hospital pharmacies

Hospital pharmacies are the preferred channel for purchasing Imiglucerase. Under the guidance of a doctor's prescription, patients can directly purchase it at the hospital pharmacy. Imiglucerase provided by hospital pharmacies usually has a regular source, guaranteed quality, and pharmacists can provide professional medication consultation.

Pharmacies

In addition to hospital pharmacies, some certified professional pharmacies also provide sales services for Imiglucerase. These pharmacies usually have long-term cooperative relationships with drug suppliers, ensuring that the source of drugs is traceable and the quality is reliable. When purchasing, patients should choose pharmacies with good reputation and carefully check the drug packaging, approval number and other information.

How effective is Imiglucerase in treatment?

Imiglucerase is a specific drug for the treatment of type 1 Gaucher disease, and its therapeutic effect is significant, bringing new hope for patients.

Improving clinical symptoms

Imiglucerase can specifically catalyze the hydrolysis of glucocerebroside, decomposing it into glucose and ceramide, thereby improving clinical symptoms such as anemia, thrombocytopenia, bone diseases, and hepatosplenomegaly in patients with Gaucher disease. Many patients have their conditions effectively controlled and their quality of life significantly improved after receiving treatment.

Delaying disease progression

Long-term application of Imiglucerase can significantly delay the progression of Gaucher disease. By continuously reducing the accumulation of glucocerebroside in the body, it protects cells from damage, thereby prolonging the survival period of patients.

Storage method of Imiglucerase

The correct storage method is crucial to the quality and efficacy of Imiglucerase. Patients should strictly follow the storage conditions specified in the instruction manual.

Temperature control

Imiglucerase should be stored in a refrigerated environment at 2-8℃, avoiding high temperature and freezing. High temperature may cause drug deterioration, while freezing may damage the structure of the drug and affect its efficacy.

Protection from light

Imiglucerase should be protected from direct sunlight during storage. Ultraviolet rays in light may have adverse effects on drug ingredients and reduce their stability. The drug should be placed in a cool, dry and dark place.

Purchasing through regular channels, using drugs rationally and storing them properly will help improve the treatment effect and the quality of life of patients.